Mylin Biotech India Private Limited - Due diligence report

A 360° intelligence report on Mylin Biotech India Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2012-12-10 Bangalore North, Karnataka Active Unlisted Active Compliant
Share
MB Mylin Biotech India Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Mylin Biotech India Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Mylin Biotech India Private Limited is assessed as Low Risk with a Trust Score of 76/100. Mylin Biotech India Private Limited is an active private limited indian non-government company incorporated in 2012, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Mylin Biotech India Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
82/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
25/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 25/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.

Charges position: 2 open (3.58 cr) · 1 satisfied (35.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Hdfc Bank Limited2 48.0 cr
Compliance Score: 82/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 2 auditor resignation(s) filed - latest: N P VALLINATH on 2020-09-24.
  • Delayed payments to MSME suppliers disclosed (1 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
KAVITHA PRABAKARAN 01234567 Director 01/04/2018 6 yrs Approved
RAMASAMY RAMAJAYAM PILLAI 01234567 Director 01/04/2018 6 yrs Approved
PANDURANGAN PRABHAKRAN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 65
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Asset base grew 0.86 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 13+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 61% in a year.
2 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 5.48 Lakh.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment47/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 3.58 cr already registered.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Sep 2022
Director ceased
PANDURANGAN PRABHAKRAN
11 May 2022
Charge satisfied
Hdfc Bank Limited
09 May 2022
Director appointed
PANDURANGAN PRABHAKRAN (Director)
02 May 2022
Securities allotted
10000 Equity Shares - 33.00 Lakh raised
19 Apr 2022
Charge created
State Bank Of India - 3.26 cr
20 May 2021
Charge created
Hdfc Bank Limited - 35.00 Lakh
09 Dec 2020
Charge created
Hdfc Bank Limited - 32.00 Lakh
10 Dec 2012
Incorporated
Registered with Roc Bangalore
Director appointed
KAVITHA PRABAKARAN (Director)
Director appointed
RAMASAMY RAMAJAYAM PILLAI (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dhanvirdhi Financial Consultants Private Limited U74140GJ2008PTC086280 Surat, Gujarat, India
Plasmos Medaids Private Limited U85100KA2012PTC065724 Mysuru, Karnataka, India
Sansar Udyog Pvt Ltd U24117OR1982PTC001033 Bhubenswar Orissa, Orissa, India
Vivati Online Private Limited U52322HR2022PTC101928 Panipat, Haryana, India
Hindustan Engineers Private Limited U22211UP1948PTC001900 Loni, Uttar Pradesh, India
Experiential Hub Private Limited U74999DL2019PTC347247 New Delhi, Delhi, India
Nara Global (India) Private Limited U26999GJ2020FTC115493 Savli, Gujarat, India
Shree Narayan Greentek Private Limited U51100KA2019PTC129194 Raichur, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Mylin Biotech India Private Limited before audits and certifications: compliance score 82/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Mylin Biotech India Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 25/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 80/100, margin trends, ownership structure and peer set for Mylin Biotech India Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Mylin Biotech India Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mylin Biotech India Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Mylin Biotech India Private Limited an active company?

Mylin Biotech India Private Limited has MCA status “Active” with a compliance score of 82/100 (Low Risk).

Is Mylin Biotech India Private Limited financially healthy?

Mylin Biotech India Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Mylin Biotech India Private Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Mylin Biotech India Private Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 3 active director(s) are on record.

Does Mylin Biotech India Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Mylin Biotech India Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 82/100 (Low Risk).

Is it risky to lend to Mylin Biotech India Private Limited?

Its Credit Risk Score is 25/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.